Federal judge indicted for allegedly helping undocumented immigrant evade ICE in her courtroom.
Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Chime Financial, a leading U.S. neobank, files for Nasdaq IPO, highlighting growth and regulatory risks.
Federal judge indicted for allegedly helping undocumented immigrant evade ICE in her courtroom.
Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Chime Financial, a leading U.S. neobank, files for Nasdaq IPO, highlighting growth and regulatory risks.